Fibryga
NDC 68982-350, Fibrinogen (Human), powder, for solution, from Octapharma USA Inc.
- Product NDC
- 68982-350
- Status
- Listed
- Labeler
- Octapharma USA Inc
- Dosage form
- POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125612
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68982-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FIBRINOGEN HUMAN20 mg/mL
Pharmacologic classes
Blood Coagulation Factors [CS]; Human Blood Coagulation Factor [EPC]; Increased Coagulation Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68982-350-01 | 68982035001 | 1 BOTTLE, GLASS in 1 CARTON (68982-350-01) / 100 mL in 1 BOTTLE, GLASS (68982-350-81) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68982-350
Use it
Look up 68982-350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68982-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68982-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.